Antigenics posts positive herpes drug study data BusinessWeek Antigenics reported positive data Tuesday from an early stage clinical therapy trial to treat herpes simplex virus-2, the virus that causes genital herpes. ... Antigenics Presents Positive, Top Line Data from Phase I Herpes Clinical Trial Antigenics shares buoyed by early data on genital herpes vax Good early results for herpes vaccine |
 Business Daily Africa | Gel's Dual Success in Simultaneously Reducing Risk of HIV and Genital Herpes ... AScribe (press release) ... a vaginal gel applied by women before and after sex cut the chance of acquiring the AIDS virus by 39 percent and the genital herpes virus by 52 percent. ... New Gel Reduces Risk Of HIV And Herpes Virus Advance on AIDS Raises Questions as Well as Joy Research Offers New Insight, Hope in the Fight Against HIV |
Antigenics reports positive top line results for herpes vaccine. Shares of ... BioMedReports (subscription) (blog) "I believe these data represent the first finding of their kind in genital herpes treatments—showing a vaccine, AG-707, elicits both CD4+ and CD8+ T-cell ... |
 The Guardian | Gel effective in preventing HIV and herpes UPI.com VIENNA, July 19 (UPI) -- A gel with an anti-retroviral drug used to treat HIV was effective in reducing a woman's risk of HIV and genital herpes, ... Study of microbicide gel shows reduced risk of HIV and herpes infections in women CAPRISA 004 trial results may provide hope for anti-HIV microbicide gels Vaginal Gel Cuts Risk of HIV Infection, Study Shows |
Research Sheds Light on How Herpes Virus Invades Cells BusinessWeek ... more about the structure and function of the cell-entry protein complex used by the herpes simplex virus type 2 (HSV-2), which causes genital herpes. ... |
Vical's Herpes Simplex Vaccines Protect Against Lethal Challenge and ... MarketWatch (press release) HSV-2 is a sexually transmitted virus which is the leading cause of genital herpes. Approximately one out of every six individuals in the United States and ... |
 Private MD | EVMS physician takes lead role in breakthrough AIDS gel for women Daily Press ... around the world for its research on a vaginal gel that promises a breakthrough in slowing the spread of both the genital herpes virus and HIV/AIDS. ... Gel found to reduce AIDS risk in women Experts Raise Questions on New AIDS' Preventive Now, a gel that can save women from getting AIDS |
Gel Reduces Herpes Transmission Rate, MPwH.net Focuses On Reducing Stigma ... Earthtimes A recent clinical study showed reduced genital herpes transmission rates. That's promising news for people with herpes trying to date in the mainstream, ... |
 Aidsmap | Scientists Proclaim Breakthrough in HIV Prevention AllAfrica.com They say the gel was also 51 percent effective in preventing genital herpes infections in the women participating in the trial. The scientists noted that ... Microbicide Success Story: What It Means and Where We Go Next Antiretroviral Gel Lowers HIV Infection and Offers Hope to Women |
Vax supply issues crimp Glaxo profits; Antigenics' battered shares buoyed by ... FierceVaccines Report Shares of Antigenics (AGEN) got some much-needed help after the developer reported that its vaccine/adjuvant combo to guard against genital herpes ... Antigenics reports positive results for herpes vaccine |
Topics
Related Topics
Related Sites
About Us
The Morefocus Media network provides news and timely information across thousands of interlinked topics from health through education, to work and lifestyle issues. Integration of a highly focused blog and community network provides consumers with the opportunity to interact with like-minded individuals and share comments, views and opinions.
Learn More >>© LendingTree, LLC.